Case Report: Lenalidomide as a novel maintenance therapy for metastatic follicular dendritic cell sarcoma - Scorecard - MDSpire

Case Report: Lenalidomide as a novel maintenance therapy for metastatic follicular dendritic cell sarcoma

  • By

  • Saarang Kashyap

  • Esha Sankhala

  • Jordan Ziegler

  • Rebecca Godin

  • Ivan Huang

  • James Heeter

  • Spencer Rosant

  • Kamlesh K. Sankhala

  • May 14, 2026

  • 0 min

Share

Clinical Scorecard: Case Study: Lenalidomide as an Innovative Maintenance Treatment for Metastatic Follicular Dendritic Cell Sarcoma

At a Glance

CategoryDetail
Condition
Key MechanismsImmunomodulation, T cell activation, NK cell activity enhancement, angiogenesis inhibition (add references).
Target Population
Care Setting

Key Highlights

  • highlight_3

Guideline-Based Recommendations

Diagnosis

  • Utilize immunohistochemical markers such as CD21, CD23, CD35, and consider additional markers for comprehensive diagnosis.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Provide more context on the patient's treatment history and response.

        Clinical Best Practices

        • monitoring

        Related Resources & Content

        Original Source(s)

        Case Report: Lenalidomide as a novel maintenance therapy for metastatic follicular dendritic cell sarcoma

        • by Saarang Kashyap, Esha Sankhala, Jordan Ziegler, Rebecca Godin, Ivan Huang, James Heeter, Spencer Rosant, Kamlesh K. Sankhala

        • May 14, 2026

        Related Content

        Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

        Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

        FOXA2 in cancer: from fundamental biology to clinical translation